Skip to main content
American Journal of Alzheimer's Disease and Other Dementias logoLink to American Journal of Alzheimer's Disease and Other Dementias
. 2015 Apr 7;30(6):541–546. doi: 10.1177/1533317515577128

Lack of Genetic Association Between TREM2 and Alzheimer’s Disease in East Asian Population

A Systematic Review and Meta-Analysis

Man Huang 1, Dejun Wang 2, Zhijun Xu 1, Yongshan Xu 1, Xiaoping Xu 2, Yuefeng Ma 1,, Zheng Xia 2,3,
PMCID: PMC10852690  PMID: 25852195

Abstract

Purpose:

Large-scale genome-wide association studies have identified TREM2 variants to be significantly associated with Alzheimer’s disease (AD) in caucasian population. The goal of this systematic study and meta-analysis was to assess the association between Triggering receptor expressed on myeloid cells 2 (TREM2) variants and AD in East Asian population.

Methods:

In this study, literatures were searched in PubMed, MEDLINE, EMBASE, and the Cochrane library to screen citations from January 1990 to June 2014. Data analysis was done by using the Stata 12 software.

Results:

Twelve studies were considered for analysis. A total of 13 535 patients with AD and 22 976 healthy controls were studied. The results showed that rs75932628 variant was significantly associated with AD in caucasian population (P < .001, odds ratio = 3.17, 95% confidence interval 2.45-4.09). However, the association was not found in East Asian population.

Conclusion:

In our study, we found that TREM2 variant is likely not associated with AD in East Asian population.

Keywords: Alzheimer’s disease, East Asian, meta-analysis, rs75932628, TREM2

Introduction

Alzheimer’s disease (AD), the most common form of dementia in the elderly patients, is a complex neurodegenerative disorder characterized by a slow but progressive loss of cognitive function. To date, genome-wide association studies have revealed several new genes associated with AD, including APOE, CR1, CLU, PICALM, MS4A4/MS4A6E, CD2AP, CD33, EPHA1, TREM2, and ABCA7. 13 Among these loci, the rare variants in TREM2 were recently identified to be associated with AD in caucasian. 4

TREM2 encodes a transmembrane glycoprotein consisting of 230 amino acid residues that is mainly expressed on osteoclasts and microglia, regulating inflammatory and phagocytic processes. 5 The rare missense variant p.R74H (rs75932628) of TREM2 was found to be associated with risk of AD in Iceland, Dutch, German, and American populations. 6 With regard to Asian population, only 4 studies have investigated TREM2 in patients with AD; however, none of them have found any association between AD and TREM2 variants including p.R47H. Because it is a possibility that TREM2 may be an ethnic-specific AD susceptibility variant, we carried out a meta-analysis to investigate the association between TREM2 variants and AD in East Asian population.

Materials and Methods

Search Strategy and Inclusion Criteria

Four databases (PubMed, EMBASE, MEDLINE, and the Cochrane library) were screened to obtain citations from January 1990 to June 2014 for inclusion in this study. The key words Alzheimer’s disease and TREM2 were used to search relevant citations. We included those studies meeting the following 2 criteria: (1) studies evaluated the association between TREM2 variants and AD by a case–control design and (2) studies provided the numbers of TREM2 genotype data. The search results were downloaded to a reference database and were further screened by 2 authors.

Data Extraction

For the case–control genetics studies, the following information was extracted from each study: (1) name of the first author, (2) year of publication, (3) ethnicity of the studied population, and (4) number of TREM2 variants genotypes (rs75932628, rs2234255, and rs2234256) in cases and controls.

Data Analysis

Data analysis was performed by using the Stata 12 (Stata Corp, College Station, Texas). For each individual study, dichotomous data were reported as odds ratio (OR) with 95% confidence interval (CI). Meta-analysis was conducted using a fixed effect model. Heterogeneity between studies was evaluated by using Cochrane Q statistics and I 2 test. Subgroup meta-analysis was conducted by single-nucleotide polymorphism (SNP) and ethnicity.

In Silico Prediction

The effects of TREM2 variants were predicted by Polymorphism Phenotyping v2 (Polyphen-2), Sorting Intolerant From Tolerant (SIFT), and SNPs&Go. The impacts of amino acid substitutions on structure and function were predicted using Polyophen-2 and SIFT. SNPs&Go was used to predict human disease-related mutations in functionally annotated proteins.

Results

Search Results and Characteristics

A total of 585 citations were obtained via database searches, among which 12 met the inclusion criteria for this study (Figure 1). Among the 12 studies identified, 5 studies were about Asian population and 7 studies were about caucasian population. A total of 8365 Asians have been involved, in which 3962 participants were patients with AD and 4403 participants were healthy controls. All 12 studies were published in full-text form. The information in these citations are summarized in Table 1.

Figure 1.

Figure 1.

Flow diagram of the studies identified.

Table 1.

Characteristics of the Trials Included in the Study.

Study Population Ethnicity No. of Case No. of Control Method
rs75932628
 Yu et al 7 Chinese East Asian 1133 1159 PCR
 Ma et al 8 Chinese East Asian 279 346 PCR
 Jiao et al 9 Chinese East Asian 360 400 PCR
 Miyashita  et al 10 Japanese East Asian 2190 2498 Taqman
 Gonzalez Murcia et al 11 American Caucasian 427 2540 Taqman
 Cuyvers  et al 12 Belgian Caucasian 1216 1094 PCR
 Benitez et al 13 Spanish Caucasian 504 550 PCR
 Ruiz et al 14 Spanish Caucasian 3172 2169 Taqman
 Guerreiro  et al 3 European and North American Caucasian 1091 1105 Taqman
 Jonsson et al 6 Icelandic Caucasian 3759 11 050 Taqman
Norwegian Caucasian 117 2484 Taqman
American Caucasian 399 402 Taqman
German Caucasian 517 1891 Taqman
Dutch Caucasian 944 4950 Taqman
 Pottier et al 15 French Caucasian 726 783 PCR
rs2234255
 Miyashita  et al 10 Japanese East Asian 2190 2498 Taqman
 Chung et al 16 Korean East Asian 400 605 Exome array
 Cuyvers  et al 12 Belgian Caucasian 1216 1094 PCR
 Guerreiro  et al 3 European and North American Caucasian 281 504 Taqman
rs2234256
 Miyashita  et al 10 Japanese East Asian 2190 2498 Taqman
 Chung et al 16 Korean East Asian 400 605 Exome array
 Cuyvers  et al 12 Belgian Caucasian 1216 1094 PCR
 Guerreiro  et al 3 European and North American Caucasian 281 503 Taqman

Abbreviation: PCR, polymerase chain reaction.

The Meta-Analysis of TREM2 Polymorphism in East Asian and Caucasian Populations

We performed a meta-analysis of the TREM2 polymorphism in both East Asian and caucasian populations with 3 SNPs, namely, rs75932628, rs2234255, and rs2234256 (Figure 2). There was a significant association between rs75932628 and AD with P < .001 (OR = 3.17, 95% CI 2.45-4.09) in caucasian population. We did not observe either rs2234255 or rs2234256 associated with AD in both East Asian and caucasian populations.

Figure 2.

Figure 2.

Forest plots for meta-analysis of the studies of TREM2 missense mutations in Alzheimer’s disease.

The Analysis of rs75932628 Polymorphism in East Asian Population

According to the meta-analysis results, the rs75932628 variant showed a strong association with AD in caucasian population. By pooling the data from Asian studies together, it was found that rs75932628 variant was rarer in East Asian population than in caucasian population. However, none of the studies has found the association between rs75932628 and AD (Table 2).

Table 2.

The rs75932628 Variant in East Asian Population.

Study Population Patients With Alzheimer’s disease Controls P Value OR (95% CI)
No. of Alleles No. of Case No. of Alleles No. of Controls
Yu et al 7 Chinese 0 1133 0 1159 NA NA
Ma et al 8 Chinese 0 279 0 346 NA NA
Jiao et al 9 Chinese 0 360 0 400 NA NA
Miyashita et al 10 Japanese 1 2190 2 2498 1 0.57 (0.05-6.30)
Chung et al 16 Korean 0 400 0 605
Total 1 4362 2 5008

Abbreviations: CI, confidence interval; OR, odds ratio; NA, not applicable.

The Variants in TREM2 Protein

In total, 9 nonsynonymous mutations have been identified in TREM2 protein (NP_061838.1) by Asian studies (Figure 3). According to Polyphen-2 results, 6 variants (p.R47H, p.D87N, p.A105V, p.G115S, p.H157Y, and p.A192T) were considered probably damaging or possibly damaging the structure or function of the TREM2 protein (Table 3).

Figure 3.

Figure 3.

Schematic position of variants in TREM2 protein.

Table 3.

In Silico Prediction of TREM2 Variants in East Asian Population.

Genomic Position Protein Position SNP Number Polyphen-2 SIFT SNP&Go Predicion Reliability Index Probability
Exon 2 41129252C>T p.Arg47His rs75932628 Probably damaging(1) Tolerated(0.11) Neutral 6 .187
41129133C>T p.Asp87Asn rs142232675 Probably damaging(1) Tolerated(0.059) Neutral 9 .054
41129078G>A p.Ala105Val rs14508091 Probably damaging(1) Damaging(0.005) Neutral 8 .089
41129049G>A p.gly115Ser Probably damaging(1) Tolerated(0.15) Neutral 8 .108
41129003C>T p.Ala130Val rs201280312 Benign(0.1) Tolerated(1) Neutral 7 .28
Exon 3 41127543G>A p.His157Tyr rs2234255 Possibly damaging(0.73) Tolerated(0.11) Neutral 8 .114
Exon 4 41126713C>T p.Ala192Thr rs150277350 Possibly damaging(0.65) Tolerated(0.14) Neutral 8 .121
41126655A>G p.Leu211Pro rs2234256 Benign(0.001) Tolerated(0.3) Neutral 10 .016
41126619G>A p.Thr223Ile rs138355759 Benign(0.005) Tolerated(0.52) Neutral 9 .028

Abbreviations: CI, confidence interval; OR, odds ratio; SIFT, Sorting Intolerant From Tolerant; SNP, single-nucleotide polymorphism.

Discussion and Conclusion

TREM2 is a transmembrane glycoprotein regulating immune system. The exact function of TREM2 remained unknown. Recently, TREM2 was identified as a novel susceptibility gene for AD in caucasian population, while there was absence of studies reporting association between TREM2 and AD in East Asian population. Consistent with previous studies, the results of our meta-analysis showed rs75932628 variant was significantly associated with AD in caucasian population, while rs2234255 and rs2234256 were not associated with AD. A total of 9370 Asians were tested for rs75932628 variant, of which only 3 cases were detected. The mutation frequency of rs75932628 in humans was lower in East Asian than in caucasian population.

To date, 5 studies have investigated TREM2 variants in East Asian population, including 3 Chinese studies, 1 Japanese study, and 1 Korean study. Yu et al’s 7 study, which consisted of 1133 AD cases and 1159 healthy controls, examined TREM2 variants in Han Chinese population. They discovered a nonsynonymous mutation located on exon2 of TREM2 that leads to amino acid substitution (p.Gly115Ser) in patients with AD. However, it was not associated with increasing AD risk. Jiao et al 9 found 2 patients with AD having missense variant rs201280312 in TREM2 with P = .13. None of the 3 studies from China have detected the rs75932628 variant. Chung et al 16 used Axiom Exome Genotyping Array to identify novel genetic variants in Korean patients with AD. Six TREM2 variants were found but none of them showed a significant association with AD. Only 3 cases of rs75932628 variant (1 AD case and 2 healthy controls) were detected in Japanese population. Unfortunately, the variant did not associate with AD. So far, there is still not enough evidence to prove that TREM2 variants increase risk of AD in East Asian population. Consistent with our study, a recent study on caucasians reported that due to the low frequency of R47H and overall modest effects on risk of AD, TREM2 variant would not possess clinical utility as a predictor or diagnostic marker for AD. 17

Totally, 9 variants of TREM2 protein have been identified in East Asian population by current studies with minor allele frequency (MAF, < 1%). 7 To evaluate the impact of these variants, we used the online prediction softwares. The results showed that 6 variants were considered to damage the structure of TREM2 protein, of which 4 variants in immunoglobulin domain involved in a wide variety of functions usually require an interaction of the intact domain with another protein or molecule. 5 The variants located in TREM2 immunoglobulin domain were detected in 2 patients with AD and 6 healthy controls. The results indicated that TREM2 was more rare variant in East Asia population compared to caucasian population. Possible explanations for this discrepancy may be that (1) variant frequency may be affected by the ethnic differences in genetic and epigenetic backgrounds. (2) Studies included in our meta-analysis were conducted in 3 major East Asian countries, thus the results seemed to be insufficient to reflect the real association in general East Asian population. (3) Lacking relevant unpublished results may lead to unexpected bias.

It was also noted that there were some limitations in our study. First, a potential weakness of this meta-analysis was caused by the fact that the included trials from Asian were different in study design. For example, Yu et al 7 screened variants on exon 2 of TREM2, while Miyashita et al 10 just chose 10 variants to investigate. This may result in some potential variants not to be detected. Second, considering the very low MAF of variants, the small sample size of our study had limited power to identify the association between TREM2 and AD. Third, the other races (eg, Latin American and African American) in the studies we included for analysis of caucasian may influence the results, as not all of these studies described the population composition. However, we think the influence is limited because the main population of the United States and European countries is caucasian.

In conclusion, we were not able to find association between TREM2 variants and AD in East Asian population. Considering the studies about caucasian, TREM2 may contribute to susceptibility of AD only in caucasians, while the association seems much weaker in East Asians. TREM2 may not be one of the risk genes for Chinese patients with AD. Large-scale studies about Asian population and other ethnicities are needed to evaluate whether TREM2 is associated with AD in Asian or only in caucasian population.

Footnotes

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by National Natural Science Foundation of China (Grant No.81271200).

References

  • 1. Hollingworth P, Harold D, Sims R, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease. Nat Genet. 2011;43 (5):429–435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Naj AC, Jun G, Beecham GW, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease. Nat Genet. 2011;43 (5):436–441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Guerreiro R, Wojtas A, Bras J, et al. TREM2 variants in Alzheimer’s disease. N Engl J Med. 2013;368 (2):117–127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Benitez BA, Jin SC, Guerreiro R, et al. Missense variant in TREML2 protects against Alzheimer’s disease. Neurobiol Aging. 2014;35 (6):1510. e1519–e1526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Abduljaleel Z, Al-Allaf FA, Khan W, et al. Evidence of TREM2 variant associated with triple risk of Alzheimer’s disease. PLoS One. 2014;9 (3):e92648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Jonsson T, Stefansson H, Steinberg S, et al. Variant of TREM2 associated with the risk of Alzheimer’s disease. N Engl J Med. 2013;368 (2):107–116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Yu JT, Jiang T, Wang YL, et al. Triggering receptor expressed on myeloid cells 2 variant is rare in late-onset Alzheimer’s disease in Han Chinese individuals. Neurobiol Aging. 2014;35 (4):937. e931–e933. [DOI] [PubMed] [Google Scholar]
  • 8. Ma J, Zhou Y, Xu J, et al. Association study of TREM2 polymorphism rs75932628 with late-onset Alzheimer’s disease in Chinese Han population. Neurol Res. 2014;36 (10):894–896. [DOI] [PubMed] [Google Scholar]
  • 9. Jiao B, Liu X, Tang B, et al. Investigation of TREM2, PLD3, and UNC5C variants in patients with Alzheimer’s disease from mainland China. Neurobiol Aging. 2014;35 (10):2422. e9–2422.e11. [DOI] [PubMed] [Google Scholar]
  • 10. Miyashita A, Wen Y, Kitamura N, et al. Lack of genetic association between TREM2 and late-onset Alzheimer’s disease in a Japanese population. J Alzheimers Dis. 2014;41 (4):1031–1038. [DOI] [PubMed] [Google Scholar]
  • 11. Gonzalez Murcia JD, Schmutz C, Munger C, et al. Assessment of TREM2 rs75932628 association with Alzheimer’s disease in a population-based sample: the Cache County Study. Neurobiol Aging. 2013;34 (12):2889. e2811–e2883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Cuyvers E, Bettens K, Philtjens S, et al. Investigating the role of rare heterozygous TREM2 variants in Alzheimer’s disease and frontotemporal dementia. Neurobiol Aging. 2014;35 (3):726. e711–e729. [DOI] [PubMed] [Google Scholar]
  • 13. Benitez BA, Cooper B, Pastor P, et al. TREM2 is associated with the risk of Alzheimer’s disease in Spanish population. Neurobiol Aging. 2013;34 (6):1711. e1715–1717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Ruiz A, Dols-Icardo O, Bullido MJ, et al. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer’s disease and frontotemporal dementia. Neurobiol Aging. 2014;35 (2):444. e441–e444. [DOI] [PubMed] [Google Scholar]
  • 15. Pottier C, Wallon D, Rousseau S, et al. TREM2 R47H variant as a risk factor for early-onset Alzheimer’s disease. J Alzheimers Dis. 2013;35 (1):45–49. [DOI] [PubMed] [Google Scholar]
  • 16. Chung SJ, Kim MJ, Kim J, et al. Exome array study did not identify novel variants in Alzheimer’s disease. Neurobiol Aging. 2014;35 (8):1958. e1913–e1954. [DOI] [PubMed] [Google Scholar]
  • 17. Hooli BV, Parrado AR, Mullin K, et al. The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk. Neurology. 2014;85 (13):1353–1358. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Alzheimer's Disease and Other Dementias are provided here courtesy of SAGE Publications

RESOURCES